Table 2.
Estimated Effects of Health Insurance Interruption on Loss of Hypertension Control Among Women's Interagency HIV Study Women, 2005–2014
| Group A: HIV-infected, health insurance | Group B: HIV-infected, health insurance or ADAP | Group C: HIV-uninfected | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | HR | 95% CI | |
| Unweighted, unadjusted | 1.29 | 0.95–1.75 | 1.40 | 1.01–1.94 | 1.24 | 0.83–1.86 |
| Weighted (marginal structural model)a | 1.37 | 0.99–1.91 | 1.47 | 1.04–2.09 | 1.39 | 0.88–2.21 |
| Weighted (marginal structural model),a censor 3 years postbreak | 1.42 | 1.00–2.02 | 1.53 | 1.04–2.23 | 1.44 | 0.91–2.29 |
a
Accounting for baseline confounders: site, race, age, and in HIV-infected women only, CD4 count and HIV viral load, as well as time-varying confounders affected by prior exposure: annual household income, body mass index, and in HIV-infected women only, CD4 count and HIV viral load.
HR, hazard ratio; CI, confidence interval.